News Quantified

DXR – daxor corporation (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Daxor Corporation CEO and President Michael Feldschuh Provides Corporate Update in Letter to Shareholders [Yahoo! Finance]

Daxor Corporation CEO and President Michael Feldschuh Provides Corporate Update in Letter to Shareholders

Daxor Corporation Reports 2025 Fiscal Year Results: Operating Revenue Up 45%, Net Asset Value Rises to $9.07 Per Share

Daxor Scales Outpatient Presence; Launches BVA Diagnostic Program in Tennessee

Daxor (NASDAQ:DXR) is now covered by analysts at Lake Street Capital. They set a "buy" rating on the stock.

Lake Street Capital

Form N-CSR DAXOR CORP For: Dec 31

Form NPORT-P DAXOR CORP For: Dec 31

Form 40-8F-2 DAXOR CORP

Form 8-K DAXOR CORP For: Jan 23

Form 424B4 DAXOR CORP

Top News Gainers

2/28 Form N-CSR DAXOR CORP For: Dec 31 65.7%

3/20 Daxor Corporation’s BVA-100® Test Used to Guide Treatment In COVID-19 Patient 28.0%

3/4 3 Biotech Stocks Join the Coronavirus Fight; Analysts Weigh In [Yahoo! Finance News] 13.0%

5/30 Daxor Corporation Announces New Partnership with Leading Hospital in North Carolina to Integrate the BVA-100® Blood Volume Analyzer Diagnostic Test as Part of Standard Clinical Practice 12.8%

4/23 Form 8-K DAXOR CORP For: Apr 23 7.6%

8/27 Form N-CSRS DAXOR CORP For: Jun 30 5.7%

8/6 Daxor Corporation Announces the Acquisition of the BVA-100® Blood Volume Analyzer by a Leading Academic Health Center in the Pacific Northwest 3.5%

11/21 Novel Study from Yale University Utilizes Daxor’s Blood Volume Analyzer (BVA-100®) to Uncover Important Mechanism for Drug Empagliflozin 3.1%

9/19 Form 40-17F2 DAXOR CORP Filed by: DAXOR CORP 2.6%

6/3 Form DEFR14A DAXOR CORP 2.5%

Top News Decliners

3/9 Daxor Corporation Contracted to Adapt Its Blood Volume Analyzer Technology for U.S. Air Force Needs -17.6%

4/23 Daxor up 4% on DoD contract for portable blood volume analyzer [Seeking Alpha] -15.2%

3/13 Form N-CEN DAXOR CORP For: Dec 31 -14.2%

3/3 Daxor Corporation Announces Pricing of $2.0 Million Registered Direct Offering Priced At-The-Market -8.2%

6/24 Form 40-APP DAXOR CORP -8.1%

4/30 Form POS 8C DAXOR CORP -8.1%

5/17 Form POS 8C DAXOR CORP -7.8%

11/12 Daxor Corporation to Exhibit at American Heart Association’s Scientific Sessions 2019 -5.1%

9/11 Daxor Corporation to Exhibit at the 23rd Annual Scientific Meeting of the Heart Failure Society of America -3.8%

9/24 Newly Published Study Demonstrates Clinical Utility of Daxor’s Blood Volume (BVA-100) Diagnostic in the Assessment of Hypertension -3.3%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day